| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/11/2014 | CA2646383C Inhibitors of lethal factor protease of anthrax toxin |
| 02/06/2014 | WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor |
| 02/06/2014 | WO2014021337A1 Compound and pharmaceutical composition for neuropsychological disorder or malignant tumor |
| 02/06/2014 | WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound |
| 02/06/2014 | WO2014019967A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof |
| 02/06/2014 | US20140039190 Benzothiazole hybrids useful as anticancer agents and process for the preparation thereof |
| 02/06/2014 | US20140039009 Compounds for inflammation and immune-related uses |
| 02/06/2014 | US20140038993 New compounds |
| 02/06/2014 | US20140038987 SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 02/06/2014 | US20140038984 Compositions and Methods for the Treatment of Metabolic and Related Disorders |
| 02/06/2014 | US20140038971 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| 02/06/2014 | US20140038970 Bridged and fused antidiabetic compounds |
| 02/06/2014 | US20140038964 Imidazole based lxr modulators |
| 02/06/2014 | US20140038962 Flavivirus Inhibitors and Methods of Their Use |
| 02/06/2014 | US20140038956 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc). |
| 02/06/2014 | US20140038948 Compounds and methods for kinase modulation, and indications therefor |
| 02/06/2014 | US20140038943 Serotonin receptor modulator |
| 02/06/2014 | US20140038937 Chromenone Derivatives |
| 02/06/2014 | US20140038936 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 02/06/2014 | US20140038919 Hepatitis c inhibitors and uses thereof |
| 02/06/2014 | US20140038821 Isoxazolines for controlling invertebrate pests |
| 02/06/2014 | US20140037754 Aminopyrimidines useful as kinase inhibitors |
| 02/06/2014 | US20140037735 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 02/05/2014 | EP2692726A1 Anti-viral compounds |
| 02/05/2014 | EP2691391A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases |
| 02/05/2014 | EP2691386A1 Quinoline derivatives as fungicides |
| 02/05/2014 | EP2691379A1 Herbicidally and fungicidally active 3-phenylisoxazoline-5-carboxamides and 3-phenylisoxazoline-5-thioamides |
| 02/05/2014 | EP2691095A2 Imidazolyl amide compounds and uses related thereto |
| 02/05/2014 | CN103562185A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/05/2014 | CN103555318A Red light material and preparation method and applications thereof |
| 02/05/2014 | CN103554100A Preparation method and application of organic solar cell material |
| 02/05/2014 | CN103554099A Preparation method of Dasatinib |
| 02/05/2014 | CN103554098A One group of 2-chlorine-3-pyridine formyl compounds |
| 02/05/2014 | CN103554097A Impurity removing method of lurasidone |
| 02/05/2014 | CN103554096A Asymmetric cyanine dye compound and application thereof |
| 02/05/2014 | CN103554095A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity |
| 02/05/2014 | CN103554026A 3-trifluoromethyl-4-formyl pyrazole compounds |
| 02/05/2014 | CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 02/04/2014 | US8642759 Benzene sulfonamide thiazole and oxazole compounds |
| 02/04/2014 | US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 02/04/2014 | US8642624 Substituted alkylamine derivatives and methods of use |
| 02/04/2014 | US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters |
| 02/04/2014 | US8642586 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same |
| 02/04/2014 | CA2655403C Antibacterial benzothiazoles and thiazolopyridines |
| 02/04/2014 | CA2624450C Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/04/2014 | CA2607426C Fused thiazole derivatives as kinase inhibitors |
| 02/04/2014 | CA2605847C Ddp-iv inhibitors for the treatment of postprandial hyperlipidemia |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 01/30/2014 | WO2014018807A1 Peptide epoxyketone compounds |
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017093A1 Benzene ring-fused, nitrogen-containing 5-membered heterocyclic compound or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017045A1 Compound having acridan ring structure, and organic electroluminescent element |
| 01/30/2014 | WO2014016296A1 Process for preparing substituted indole derivatives |
| 01/30/2014 | WO2013184476A3 Processes to produce certain 2-(pyridine-3-yl)thiazoles |
| 01/30/2014 | US20140031548 Process of a quaternary ammonium salt using phosphate |
| 01/30/2014 | US20140031544 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 01/30/2014 | US20140031378 Insecticidal spironindane derivatives |
| 01/30/2014 | US20140031360 Bicyclic compounds as pim inhibitors |
| 01/30/2014 | US20140031353 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | US20140031346 5,6-dihydro-1h-pyridin-2-one compounds |
| 01/30/2014 | US20140031345 Quinazolines as potassium ion channel inhibitors |
| 01/30/2014 | US20140031335 Cycloalkenyl aryl derivatives for cetp inhibitor |
| 01/30/2014 | US20140031330 ARYL SULTAM DERIVATIVES AS RORc MODULATORS |
| 01/30/2014 | US20140031329 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 01/30/2014 | US20140030223 Inhibitors of flaviviridae viruses |
| 01/29/2014 | EP2690091A1 Process for preparing substituted indole derivatives |
| 01/29/2014 | EP2689780A1 Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group |
| 01/29/2014 | EP2688886A1 Azole compounds as pim inhibitors |
| 01/29/2014 | EP2688881A1 New azaspirodecanone compounds as hsl inhibitors |
| 01/29/2014 | EP2688870A1 Heterocyclic amine derivatives |
| 01/29/2014 | EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN103547575A Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 01/29/2014 | CN103547566A Aminoindane compounds and use thereof in treating pain |
| 01/29/2014 | CN103547263A Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 01/29/2014 | CN103539794A Salifying method of lurasidone hydrochloride |
| 01/29/2014 | CN103539793A Thiazole carboxamide compounds and application thereof |
| 01/29/2014 | CN103539792A Cyan-substituted asymmetric cyanine compound, and preparation method and application thereof |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |
| 01/29/2014 | CN103539716A One group of 2-para chlorphenyl-4-substituted methyl-5- trifluoromethyl-3-cyanpyrrole compounds |
| 01/29/2014 | CN102245598B 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication |
| 01/29/2014 | CN101801958B Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2014 | CN101679355B Benzimidazole cannabinoid agonists |
| 01/29/2014 | CN101228154B Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 01/28/2014 | US8637548 Therapeutic agents useful for treating pain |
| 01/28/2014 | US8637546 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) |
| 01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
| 01/28/2014 | US8637505 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/28/2014 | US8637498 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors |
| 01/28/2014 | CA2685266C Trpv1 antagonists and uses thereof for the treatment of prevention of pain, ui and ulcer, ibd, or ibs in an animal |
| 01/28/2014 | CA2631741C Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 01/28/2014 | CA2568008C Process for preparing acyclic hcv protease inhibitors |
| 01/28/2014 | CA2560373C 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014015280A1 Combination therapy of inhibitors for igf1 r and pi3k |
| 01/23/2014 | WO2014015088A1 Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase |
| 01/23/2014 | WO2014014874A1 Pyrazole derivatives which inhibit leukotriene production |